Aug 18, 2025
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
Dec 26, 2024
Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
Mar 21, 2024
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
Mar 21, 2024
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
Feb 06, 2024
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
Oct 05, 2020
Northwest Biotherapeutics Announces Data Lock of Phase III Trial
Sep 01, 2020
Northwest Biotherapeutics Acquires Flaskworks
Aug 27, 2020
NW Bio Accelerating Sawston Plant Phase I Buildout
Aug 19, 2020
NW Bio Announces Completion of Further Data Gathering For Phase III Trial
Jul 24, 2020
Northwest Biotherapeutics Announces Completion of Phase 3 Trial Sites' Databases
Jun 02, 2020
NW Bio Provides Update On Projected Timing For Data Lock For Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer
Apr 18, 2020
NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting
Feb 18, 2020
NW Bio Announces Annual Shareholders' Meeting Scheduled for April 18, 2020
Dec 12, 2019
Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team
Dec 11, 2019
Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit
Oct 10, 2019
NW Bio Moves Forward With SEC Settlement
Sep 04, 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
May 30, 2019
NW Bio To Present Updates On DCVax® Clinical Programs In Industry Theater Presentation At ASCO
May 28, 2019
NW Bio Announces Settlement with Cognate BioServices Resolving Past Matters and Providing for Restart of DCVax®-Direct Production
Mar 05, 2019
Biotech Companies Intensify Research Into New Therapies to Combat Cancer